FindTrial
Sign In

Pharmacist intervention reduces vancomycin induced acute kidney injury: a cohort study

Pharmacist intervention reduces vancomycin induced acute kidney injury: a cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094888
Enrollment
Unknown
Registered
2024-12-30
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury

Interventions

Pharmacist intervention group VS control group:NA

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (a) Informed consent of donors with health-related information for Biobank has been signed. (b) patients treated with vancomycin for anti-infective treatment

Exclusion criteria

Exclusion criteria: (a) Stage 5 chronic kidney disease or regular dialysis, (b) renal transplant status or solitary kidney, (c) non-intravenous vancomycin, (d) vancomycin treatment for less than 48 hours (e) Inadequate measurement of serum creatinine (SCr)

Design outcomes

Primary

MeasureTime frame
Serum creatinine;—

Countries

China

Contacts

Public ContactKunming Pan

Zhongshan Hospital Fudan University

panxso@163.com+86 150 2662 9516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026